Frequent potassium monitoring is associated with hyperkalemia that is clinically insignificant in females taking spironolactone for dermatologic conditions

Indian J Dermatol Venereol Leprol. 2024 Sep-Oct;90(5):659-661. doi: 10.25259/IJDVL_1280_2023.

Authors

Rachel C Hill¹, Yu Wang², Bilal Shaikh³, Paul J Christos³, Shari R Lipner⁴

Affiliations

¹ Weill Cornell Medical College, New York, United States.
² Department of Dermatology, Wake Forest School of Medicine, Wake Forest, NC, United States.
³ Division of Biostatistics, Department of Population Health Sciences, Weill Cornell Medicine, New York, United States.
⁴ Department of Dermatology, Weill Cornell Medicine, New York, United States.

PMID: 39152866
DOI: 10.25259/IJDVL_1280_2023

No abstract available

Publication types

Letter

MeSH terms

Adult
Female
Humans
Hyperkalemia* / blood
Hyperkalemia* / chemically induced
Hyperkalemia* / diagnosis
Middle Aged
Mineralocorticoid Receptor Antagonists / adverse effects
Mineralocorticoid Receptor Antagonists / therapeutic use
Potassium* / blood
Skin Diseases / diagnosis
Skin Diseases / drug therapy
Spironolactone* / adverse effects
Spironolactone* / therapeutic use

Substances

Spironolactone
Potassium
Mineralocorticoid Receptor Antagonists